Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
MINNEAPOLIS, Dec 21, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the beginning of its Medtronic CoreValve(R) U.S. Pivotal clinical trial in the United States. The first...
MINNEAPOLIS, Dec 20, 2010 (BUSINESS WIRE) -- Medtronic (NYSE:MDT) announced today that William A. Hawkins intends to retire as Chairman and CEO of Medtronic at the conclusion of the current fiscal...
MINNEAPOLIS, Dec 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has approved its Arctic Front(R) Cardiac CryoAblation...
MINNEAPOLIS, Dec 09, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) has received CE (Conformité Européenne) Mark for the Medtronic CoreValve(R) System to be delivered through a novel...
MINNEAPOLIS, Dec 09, 2010 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock. The dividend is...
MEMPHIS, Tenn., Dec 02, 2010 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it received clearance to treat adolescent idiopathic scoliosis (AIS). This marks the first such clearance by...
MINNEAPOLIS, Dec 02, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left...
MINNEAPOLIS & NEW YORK, Nov 19, 2010 (BUSINESS WIRE) -- An implantable medical device used in the minimally invasive treatment of abdominal aortic aneurysms, the Endurant(R) Stent Graft System...
MINNEAPOLIS, Nov 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2011, which ended October 29, 2010. The company...
MINNEAPOLIS & MOUNTAIN VIEW, Calif., Nov 22, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and privately-held Ardian, Inc. announced today that they have entered into a merger agreement...
MINNEAPOLIS, Nov 19, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the publication of data showing that use of its Reveal(R) family of Insertable Cardiac Monitors led to...
MINNEAPOLIS & NEW YORK, Nov 19, 2010 (BUSINESS WIRE) -- An implantable medical device used in the minimally invasive treatment of thoracic aortic aneurysms,the Valiant(R) Thoracic Stent Graft...
MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch and first clinical use of the Tri-Ad(TM) Semi-Flexible Tricuspid Annuloplasty Ring for...
MINNEAPOLIS, Nov 17, 2010 (BUSINESS WIRE) -- Improving the efficiency of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), today introduced EVARpro(R), a suite of value-added...
MEMPHIS, Tenn., Nov 16, 2010 (BUSINESS WIRE) -- Moving to expand its Biologics product offerings, Medtronic, Inc. (NYSE: MDT), announced today it has completed the acquisition of Osteotech,...
TOLOCHENAZ, Switzerland, Nov 15, 2010 (BUSINESS WIRE) -- Medtronic today launched Medtronic Eureka, a European web-based portal for medical technology innovation designed to help physicians and...
REDMOND, Wash., Nov 15, 2010 (BUSINESS WIRE) -- Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced today it has received 510(k) clearance from the U.S. Food...
SAN ANTONIO & REDMOND, Wash., Nov 15, 2010 (BUSINESS WIRE) -- Innovative new mobile cardiac monitoring solutions are on the horizon. At the American Heart Association Scientific Sessions 2010,...
MINNEAPOLIS & CHICAGO, Nov 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the landmark RAFT (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial)...
MINNEAPOLIS, Nov 12, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2011 on Tuesday, November 23,...
MINNEAPOLIS, Nov 04, 2010 (BUSINESS WIRE) -- In support of Bladder Health Awareness Month and the struggles 33 million Americans face year-round with bladder control issues, Medtronic, Inc. (NYSE:...
MINNEAPOLIS, Nov 01, 2010 (BUSINESS WIRE) -- Advancing the minimally invasive treatment of aortic aneurysms, Medtronic, Inc. (NYSE: MDT), today announced approval by the U.S. Food and Drug...
MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT), the leader in spinal cord stimulation for more than 25 years, today announced U.S. Food and Drug Administration (FDA)...
MINNEAPOLIS, Oct 29, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the...
MINNEAPOLIS, Oct 21, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced Food and Drug Administration (FDA) clearance of the Kyphon Xpander II Inflatable Bone Tamp (IBT) for the...